#$%^&*AU2016201888A120160421.pdf#####H: dar lnterwoven NRPortbl DCC DAR 9884144_1.doc-3/24/2016 ABSTRACT The invention concerns the use of cyclophilin inhibitors (such as alisporivir) in the treatment of 5 Hepatitis B and Hepatitis D virus infections, optionally in combination with interferon or telbivudine, lamivudine, emtricitabine, entecavir, adefovir or tenofovir.